News
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan
KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of a generic product for filing in Japan. KYOWA will be the first...
News
Metrics Contract Services Appoints Senior Director of Scientific and Technical Affairs
Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, welcomes Anshul Gupte, PhD as Senior Director, Scientific and Technical Affairs.
In that capacity, Anshul will be responsible for technical and scientific oversight of client projects. He...
News
Stelis Biopharma appoints Mark W. Womack as the new CEO
Stelis Biopharma Limited (Stelis or Company), a vertically integrated biopharma and vaccines Company and the biotech arm of Strides Pharma Science Limited, announced the appointment of Mark W. Womack (Mark) as the new Chief Executive Officer (CEO).
Mark is also the Managing...
News
Virus Safety in Continuous Processes
Virus safety is a key element in biopharmaceutical manufacturing. Inherently, animal cell culture involves risks related to virus safety. Chinese Hamster Ovary (CHO) cell lines are the most common production platform for expressing glycosylated proteins and monoclonal antibodies. Being...
Clinical Trials
Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced positive topline results from the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate,...
News
What Is Gene Therapy? How Does It Save and Improve the Quality of Life?
What Is Gene Therapy?
Gene therapy is a new and exciting technique, defined as the use of genetic material to cure or alleviate disease. It is considered revolutionary, yet still in its infancy, with many new therapies currently undergoing clinical trials.
Gene...
News
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility
Emergent BioSolutions Inc. announced that the U.S. FDA is allowing Emergent’s Bayview manufacturing facility to resume production of Johnson & Johnson’s (J&J) Covid-19 vaccine bulk drug substance. This resumption of manufacturing follows extensive reviews by FDA, weeks of diligent...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.